A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

NCT00502736 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain; Bone Neoplasms; Neoplasm Metastasis

Interventions

DRUG: ibandronate [Bondronat]

Sponsor

Hoffmann-La Roche